MiniEpi made a smaller, more convenient and accessible adrenaline auto-injector device to provide for those individuals who suffer from anaphylaxis. MiniEpi developed a device and patented their prototype, while making and growing traction within the allergy community in Australia. With their main ...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2016 (9 years)
Address:
MICHEAL CROUCH INNOVATION CENTRE; GATE 2 UNSW; KENSINGTON, NSW 2033, AU
LOW
spending power
